8-K
Current Report
X4 Pharmaceuticals, Inc Filed Acc 0001501697-26-000081
Material agreement · Agreement ended · New debt or obligation · Unregistered share sale · Regulation FD disclosure
- Item 1.01 Entry into a material definitive agreement
- Item 1.02 Termination of a material definitive agreement
- Item 2.03 Creation of a direct financial obligation
- Item 3.02 Unregistered sales of equity securities
- Item 7.01 Regulation FD disclosure
From the SEC's structured data for this filing
Loading xfor-20261007.htm…